Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Am J Hematol. 2010 Aug;85(8):616–619. doi: 10.1002/ajh.21754

Table 3.

Bone Marrow Vessels Density during Bortezomib Trial in 15 Patients who had Serial Bone Marrow Specimens Available for Review

Case Bortezomib dose mg/m2 Number of vessels (×10−3μ2) Change from baseline (%)
Baseline Final
1 0.8 1.41 2.54 80.1
2 0.8 2.33 2.78 19.3
3 0.8 2.66 2.17 −18.4
4 1 3.32 3.02 −9.0
5 1 2.17 2.14 −1.4
6 1.3 1.30 2.49 91.5
7 1.3 2.66 1.40 −47.4
8 1.3 3.65 1.79 −50.9
9 1.3 1.92 2.43 26.5
10 1.3 4.09 3.20 −21.8
11 1.3 2.76 2.77 0.4
12 1.3 4.56 3.15 −30.9
13 1.3 5.93 3.41 −42.5
14 1.3 2.06 2.30 11.6
15 1.3 3.96 2.54 −36.1
Median 2.66 2.53 −9.03